Literature DB >> 32026136

Heart rate variability and falls in Huntington's disease.

Daniel E Vigo1,2,3, Marcelo Merello4,5, Cinthia Terroba-Chambi6,1, Veronica Bruno7.   

Abstract

PURPOSE: Persons with Huntington's disease (HD) have a high incidence of falls. Autonomic nervous system dysfunction has been reported even in early stages of this disease. To date, there has been no analysis of the relationship between heart rate variability (HRV) and falls in this patient population. The aim of the study reported here was to evaluate the relationship between HRV and falls in persons with HD.
METHODS: Huntington's disease patients enrolled in a prospective study on fear of falling and falls were assessed using short-term HRV analyses and blood pressure measures in both the resting and standing states. Time-frequency domains and nonlinear parameters were calculated. Data on falls, the risk of falling (RoF) and disease-specific scales were collected at baseline and at the end of the 6-month follow-up.
RESULTS: Of the 24 HD patients who were invited to participate in the study, 20 completed the baseline analysis and 18 completed the 6-month follow-up. At baseline, seven (35%) HD patients reported at least one fall (single fallers) and 13 (65%) reported ≥ 2 falls (recurrent fallers) in the previous 12 months. At baseline, recurrent fallers had lower RMSSD (root mean square of successive RR interval differences) in the resting state (RMSSD-resting), higher LF/HF (low/high frequency) ratio in both states and higher DFA-α1 parameter (detrended fluctuation analyses over the short term) in both states. This association was similar at the 6-month follow-up for recurrent fallers, who showed lower RMSSD-resting and higher LF/HF ratio in the standing state (LF/HF-standing) than single fallers. Significant correlations were found between the number of falls, RMSSD-resting and LF/HF-standing. No differences were found between recurrent and single fallers for any blood pressure measures.
CONCLUSIONS: The observed HRV pattern is consistent with a higher sympathetic prevalence associated with a higher RoF. Reduced parasympathetic HRV values in this patient population predict being a recurrent faller at 6 months of follow-up, independently of orthostatic phenomena.

Entities:  

Keywords:  Autonomic nervous system; Fall prediction; Heart rate variability; Huntington’s disease; Risk of falling

Year:  2020        PMID: 32026136     DOI: 10.1007/s10286-020-00669-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  34 in total

1.  Early sympathetic hyperactivity in Huntington's disease.

Authors:  J Kobal; B Meglic; A Mesec; B Peterlin
Journal:  Eur J Neurol       Date:  2004-12       Impact factor: 6.089

2.  Fall Prediction in Hypertensive Patients via Short-Term HRV Analysis.

Authors:  Rossana Castaldo; Paolo Melillo; R Izzo; N De Luca; Leandro Pecchia
Journal:  IEEE J Biomed Health Inform       Date:  2016-03-18       Impact factor: 5.772

3.  Autonomic nervous system function in Huntington's disease.

Authors:  J Andrich; T Schmitz; C Saft; T Postert; P Kraus; J T Epplen; H Przuntek; M W Agelink
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

4.  Falls and gait disturbances in Huntington's disease.

Authors:  Yvette A M Grimbergen; Mirjam J Knol; Bastiaan R Bloem; Berry P H Kremer; Raymund A C Roos; Marten Munneke
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

5.  Cardiovagal modulation upon postural change is altered in Huntington's disease.

Authors:  K J Bär; M K Boettger; J Andrich; J T Epplen; F Fischer; J Cordes; M Koschke; M W Agelink
Journal:  Eur J Neurol       Date:  2008-05-15       Impact factor: 6.089

6.  Falls in frequent neurological diseases--prevalence, risk factors and aetiology.

Authors:  Henning Stolze; Stephan Klebe; Christiane Zechlin; Christoph Baecker; Lars Friege; Günther Deuschl
Journal:  J Neurol       Date:  2004-01       Impact factor: 4.849

Review 7.  The central autonomic network: functional organization, dysfunction, and perspective.

Authors:  E E Benarroch
Journal:  Mayo Clin Proc       Date:  1993-10       Impact factor: 7.616

8.  Physical therapy intervention for people with Huntington disease.

Authors:  Monica E Busse; Hanan Khalil; Lori Quinn; Anne E Rosser
Journal:  Phys Ther       Date:  2008-05-08

9.  Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases.

Authors:  T L Jernigan; D P Salmon; N Butters; J R Hesselink
Journal:  Biol Psychiatry       Date:  1991-01-01       Impact factor: 13.382

10.  Predictors of nursing home placement in Huntington disease.

Authors:  V L Wheelock; T Tempkin; K Marder; M Nance; R H Myers; H Zhao; E Kayson; C Orme; I Shoulson
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

View more
  5 in total

Review 1.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

2.  Cardiovascular Autonomic Dysfunction and Falls in People With Multiple Sclerosis: Is There a Link? An Opinion Article.

Authors:  Tobia Zanotto; Manuel E Hernandez; Cristina N Medrano; Kenneth R Wilund; Jacob J Sosnoff
Journal:  Front Neurosci       Date:  2020-12-07       Impact factor: 4.677

3.  Psychological status and physical performance are independently associated with autonomic function.

Authors:  Nur Husna Shahimi; Choon-Hian Goh; Sumaiyah Mat; Renly Lim; Vivian Ci Ai Koh; Samuel R Nyman; Maw Pin Tan; Einly Lim
Journal:  Biomed Eng Online       Date:  2022-05-05       Impact factor: 3.903

Review 4.  Purine Nucleotides Metabolism and Signaling in Huntington's Disease: Search for a Target for Novel Therapies.

Authors:  Marta Tomczyk; Talita Glaser; Ewa M Slominska; Henning Ulrich; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 5.  Falls Risk, Circadian Rhythms and Melatonin: Current Perspectives.

Authors:  Nandu Goswami; Carolina Abulafia; Daniel Vigo; Maximilian Moser; Germaine Cornelissen; Daniel Cardinali
Journal:  Clin Interv Aging       Date:  2020-11-11       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.